PRME (STOCKS)
Prime Medicine, Inc. Common Stock
$3.689900
+0.259900 (+7.58%)
Prev close: $3.430000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Allan Jacob Reine
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $660.82M
- Employees
- 214
- P/E (TTM)
- -2.66
- P/B (TTM)
- 5.12
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
5
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.26 | $-0.26 | -0.0036 | -1.40% |
|
Sep 2025 (Q3)
|
$-0.32 | $-0.26 | -0.0619 | -23.98% |
|
Jun 2025 (Q2)
|
$-0.41 | $-0.37 | -0.0391 | -10.54% |
|
Mar 2025 (Q1)
|
$-0.40 | $-0.33 | -0.0735 | -22.51% |
Financial Statements
| Revenues | $4.63M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $212.98M |
| Nonoperating Income/Loss | $7.21M |
| Operating Expenses | $212.98M |
| Research and Development | $160.64M |
| Other Operating Expenses | $52.35M |
| Operating Income/Loss | -$208.35M |
| Income/Loss From Continuing Operations After Tax | -$201.14M |
| Income/Loss From Continuing Operations Before Tax | $4.63M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$201.14M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$201.14M |
| Net Income/Loss Available To Common Stockholders, Basic | -$201.14M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.35 |
| Diluted Earnings Per Share | -$1.35 |
| Basic Average Shares | 148,758,527 |
| Diluted Average Shares | 148,758,527 |
| Assets | $342.73M |
| Current Assets | $181.29M |
| Cash | $177.70M |
| Prepaid Expenses | $2.94M |
| Other Current Assets | $654.00K |
| Noncurrent Assets | $161.44M |
| Fixed Assets | $20.57M |
| Other Non-current Assets | $140.87M |
| Liabilities | $221.87M |
| Current Liabilities | $37.45M |
| Accounts Payable | $8.89M |
| Wages | $7.34M |
| Other Current Liabilities | $21.22M |
| Noncurrent Liabilities | $184.42M |
| Equity | $120.87M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $120.87M |
| Liabilities And Equity | $342.73M |
| Net Cash Flow From Operating Activities | -$162.56M |
| Net Cash Flow From Operating Activities, Continuing | -$162.56M |
| Net Cash Flow From Investing Activities | -$108.76M |
| Net Cash Flow From Investing Activities, Continuing | -$108.76M |
| Net Cash Flow From Financing Activities | $151.51M |
| Net Cash Flow From Financing Activities, Continuing | $151.51M |
| Net Cash Flow | -$119.82M |
| Net Cash Flow, Continuing | -$119.82M |
| Comprehensive Income/Loss | -$201.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$201.06M |
| Other Comprehensive Income/Loss | -$201.06M |